Inflammation

• 1. Introduction

  ›

  Inflammation is one of the oldest documented phenomena in medicine, described by the Roman scholar Celsus around 30 BC with four words that still appear in medical textbooks today: calor, dolor, rubor, tumor. Heat. Pain. Redness. Swelling. A fifth sign, loss of function, was added later, attributed variously to Galen, Thomas Sydenham, or Rudolf Virchow. For two thousand years, these five cardinal signs have served as the fingerprints of a process that both saves lives and, when it overstays its welcome, quietly destroys them.

  What exactly is happening inside a body when these signs appear? And why would the same biological response that fights off a bacterial infection also play a central role in heart disease, depression, cancer, and AIDS? Those are the questions this documentary will explore.

• 2. The Body's First Alarm

  ›

  Within minutes of an injury, the body's resident immune cells spring into action. Macrophages, dendritic cells, histiocytes, Kupffer cells, and mast cells already stationed in the tissue carry surface receptors called pattern recognition receptors. These receptors scan for two categories of molecular distress signals: pathogen-associated molecular patterns, or PAMPs, which flag the presence of an invader, and damage-associated molecular patterns, or DAMPs, which flag the body's own injured cells.

  Once a receptor binds to either signal, the cell releases a cascade of mediators. Histamine and serotonin are released by macrophages and mast cells. Prostaglandin E2 and leukotriene B4 follow. Macrophages and endothelial cells release nitric oxide. Together these compounds cause the local blood vessels to widen and become leaky, allowing plasma fluid to flood into the surrounding tissue. That flooding is the swelling a person feels after twisting an ankle. The increased blood flow is the heat and redness. Bradykinin, one of the released molecules, directly stimulates nerve endings to produce pain.

  The plasma that leaks into tissue does not arrive empty. It carries complement proteins, lysozyme, and antibodies that can immediately damage microbes. If a wound is involved, platelets, coagulants, plasmin, and kinins cooperate through vitamin K-dependent mechanisms to clot the area. The resulting fibrin lattice acts as a structural scaffold for the repair work that follows, functioning much as construction scaffolding surrounds a building under renovation.

• 3. Leukocytes on the Move

  ›

  Neutrophils are the first immune cells dispatched into inflamed tissue, and getting them there requires a precisely orchestrated sequence of molecular handshakes between the cells and the blood vessel walls. Activated macrophages release cytokines, including IL-1 and TNF-alpha, which trigger the immediate display of P-selectin on the inner surface of blood vessels. P-selectin binds weakly to molecules on the surface of passing white blood cells, causing them to slow down and roll along the vessel wall like a ball slowing on a textured surface.

  Cytokines then prompt the expression of integrin ligands, ICAM-1 and VCAM-1, on endothelial cells, which bind the rolling leukocytes more firmly. Once firmly adhered, the leukocytes squeeze between adjacent endothelial cells in a process called diapedesis, pass through the basement membrane, and enter the tissue. There, molecules such as C3a and C5a guide them along a chemical trail toward the precise site of injury.

  Once at the site, neutrophils begin phagocytosis: engulfing bacteria and debris by wrapping membrane around the target to create a phagosome, then fusing that phagosome with a lysosome. Inside the phagolysosome, reactive oxygen species including superoxides and hypochlorite destroy the trapped microbe. The process is made more efficient by opsonization, in which complement protein C3b and antibodies coat microbial surfaces and bind to matching receptors on the phagocyte, dramatically increasing the speed and reliability of engulfment.

• 4. When Acute Becomes Chronic

  ›

  Acute inflammation is designed to be self-limiting. Inflammatory mediators are short-lived and degrade quickly in tissue once the triggering stimulus is removed. An active resolution program begins within hours of the response starting. Granulocytes trigger a chemical switch from prostaglandins and leukotrienes to lipoxins, which initiate a shutdown sequence. Neutrophil recruitment ceases. The cells undergo apoptosis, a form of programmed cell death. Omega-3 polyunsaturated fatty acids contribute to the biosynthesis of resolvins and protectins, which accelerate neutrophil clearance. Macrophages consume the apoptotic neutrophils and release anti-inflammatory cytokines, including transforming growth factor-beta 1. The macrophages themselves then exit through the lymphatic system.

  When this shutdown fails, the inflammation does not resolve. Chronic inflammation can persist for months or years. The cellular population at the site shifts from neutrophils to macrophages, lymphocytes, and plasma cells. Rather than repairing tissue, chronic inflammation is almost always accompanied by tissue destruction. The macrophages that would otherwise coordinate repair release reactive oxygen species that damage the body's own structures.

  The diseases associated with chronic inflammation span a striking range: hay fever, periodontal disease, atherosclerosis, osteoarthritis, diabetes, cardiovascular disease, allergies, and chronic obstructive pulmonary disease. Obesity, smoking, stress, and insufficient diet are among the factors that sustain this low-grade persistent state. In obesity specifically, markers including IL-6, TNF-alpha, and C-reactive protein are elevated at two to three times normal concentrations, and waist circumference correlates significantly with systemic inflammatory response.

• 5. Inflammation and Cancer

  ›

  In 1863, Rudolf Virchow proposed that cancer originates at sites of chronic inflammation. As of 2012, chronic inflammation was estimated to contribute to approximately 15 to 25 percent of human cancers.

  The mechanism involves DNA damage. Reactive oxygen species and reactive nitrogen species, produced by leukocytes to fight infection, can inflict more than 20 types of DNA damage when chronically present. Oxidative damage causes both genetic mutations and epigenetic changes. A typical cancer cell may carry roughly 100 mutations in coding regions, of which 10 to 20 are driver mutations that actively push tumor development. But epigenetic changes, particularly DNA methylation, are often more numerous than mutations: several hundreds to thousands of genes can be methylated in a single cancer cell.

  A 2018 analysis compared the relative weight of mutations versus epigenetic changes in two cancer types. In gastric cancer, which is associated with inflammation, epigenetic alterations were the more significant factor. In esophageal squamous cell cancer, linked to tobacco chemicals and acetaldehyde from alcohol metabolism, mutations and epigenetic changes contributed roughly equally.

  Cancer cells also exploit the inflammatory machinery for their own purposes. They use selectins, chemokines, and chemokine receptors to invade surrounding tissue, migrate, and metastasize. Inflammatory mediators including prostaglandins, IL-1 beta, TNF-alpha, IL-6, IL-15, IL-8, and GRO-alpha build a microenvironment that supports tumor survival and proliferation. The same molecular intersection between steroid hormone receptors and inflammation-related transcription factors such as NF-kappa B may represent a future therapeutic target, since attacking a specific protein domain in a specific cell type could limit side effects unrelated to the tumor.

• 6. HIV, AIDS, and Pyroptosis

  ›

  HIV infection has long been understood as a disease of immunodeficiency, but researchers have come to recognize it equally as a chronic inflammatory disease. Even after effective antiretroviral therapy suppresses viral replication in infected individuals, chronic inflammation persists.

  Animal studies illustrate the relationship sharply. The sooty mangabey, a natural host of SIVsm, a close relative of HIV, sustains high-level viral replication without developing disease. That absence of illness is accompanied by an absence of inflammation and immune activation. When the same virus infects rhesus macaques, immune activation follows, along with AIDS-like disease that closely parallels human HIV infection.

  Research identified a specific cell death pathway as central to the inflammation driving HIV disease progression. Caspase-1-mediated pyroptosis, a highly inflammatory form of programmed cell death, drives the depletion of CD4 T cells that characterizes AIDS. As infected CD4 T cells die through pyroptosis, they release inflammatory signals that recruit more cells into infected lymphoid tissues, where those cells also die. This feed-forward cycle sustains the chronic inflammation and tissue injury that propels the disease.

  A caspase-1 inhibitor called VX-765 has shown in phase II human clinical trials that it can block pyroptosis of CD4 T cells and suppress secretion of pro-inflammatory cytokines including IL-1 beta and IL-18 in HIV-infected human lymphoid tissues. The approach would target the host's own inflammatory response rather than the virus directly, and would almost certainly be used alongside antiretroviral therapy. The sooty mangabey's evolutionary tolerance of its lentivirus without immune decline serves as a biological proof of concept for this direction.

• 7. The Mind and the Body's Fire

  ›

  A 2019 meta-analysis found that chronic inflammation is associated with a 30 percent increased risk of developing major depressive disorder. The link runs in both directions. Negative cognitions, and their downstream consequences such as stress, violence, or deprivation, can themselves trigger inflammatory processes. Those inflammatory processes can then promote depression, in part by elevating cytokines that push the brain into what researchers describe as a sickness mode.

  The behavioral overlap between physical illness and depression is not coincidental. Lethargy, a classical symptom of being sick, appears prominently in depression. In people with bipolar disorder, cytokine levels tend to rise sharply during depressive episodes and fall during remission. Clinical trials have shown that anti-inflammatory medicines taken alongside antidepressants not only improve symptoms more than antidepressants alone but also increase the proportion of patients who respond to treatment at all.

  Common infections, including those caused by viruses, bacteria, and even parasites, can apparently trigger the inflammatory cascade that leads to serious depression. Separate evidence points to a link between inflammation and delirium, drawn from a longitudinal study tracking C-reactive protein levels in COVID-19 patients. C-reactive protein, a marker of inflammation generated at higher levels in obese individuals, also prospectively identifies risk of atherosclerotic complications, independently of LDL levels.